Taylor Pak

FDA Grants Approval to Repotrectinib for Locally Advanced or Metastatic Non-Small Cell Lung Cancer

December 6th 2023  /  12:15 PM PST By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On November 15, 2023, the U.S. Food…

1 year ago

Binaytara Foundation Announces 2023 Career Advancement Award Recipients

The Binaytara Foundation has proudly announced the 2023 Binaytara Career Advancement Awards recipients. The recipients of the 2023 awards attended…

1 year ago

FDA Approves Fruquintinib for Metastatic Colorectal Cancer with Prior Treatment History

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On November 8, 2023, the U.S. Food and Drug Administration granted approval to Fruquintinib…

1 year ago

Dr. Binay Shah Delivers a Keynote Lecture at the 2023 Global Oncology Summit

By: BTF Staff   October 28, 2023 – Known for its unwavering commitment to improving access to cancer care in…

1 year ago

KEYNOTE-564 trial: KEYTRUDA® (pembrolizumab) Improves Overall Survival in Renal Cell Carcinoma Patients Post-Nephrectomy

By: Dr. Anish Shah  Bronx-Lebanon Hospital; Bronx, NY Merck's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), significantly improves overall survival (OS) in renal cell…

1 year ago